Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1950 2
1951 2
1952 1
1953 3
1955 3
1956 4
1958 1
1959 5
1960 1
1962 1
1963 2
1964 1
1965 2
1966 2
1967 10
1968 6
1969 5
1970 6
1971 6
1972 10
1973 7
1974 8
1975 5
1976 6
1977 10
1978 13
1979 10
1980 13
1981 6
1982 13
1983 12
1984 14
1985 19
1986 15
1987 21
1988 18
1989 18
1990 25
1991 18
1992 18
1993 23
1994 20
1995 29
1996 30
1997 23
1998 31
1999 23
2000 38
2001 38
2002 29
2003 33
2004 42
2005 58
2006 72
2007 61
2008 59
2009 44
2010 59
2011 69
2012 58
2013 53
2014 59
2015 63
2016 78
2017 79
2018 81
2019 85
2020 93
2021 75
2022 52
2023 60
2024 67
2025 57
2026 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,993 results

Results by year

Filters applied: . Clear all
Page 1
AUTHOR REPLY.
Williams C, Familusi O, Kovell RC, Wein AJ, Butler PD, Lloyd-Harris JE. Williams C, et al. Among authors: butler pd. Urology. 2023 Apr;174:34. doi: 10.1016/j.urology.2022.09.047. Urology. 2023. PMID: 37030914 No abstract available.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Emmett L, Subramaniam S, Crumbaker M, Nguyen A, Joshua AM, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Gedye C, Rutherford NK, Sandhu S, Kumar AR, Pook D, Ramdave S, Nadebaum DP, Voskoboynik M, Redfern AD, Macdonald W, Krieger L, Schembri G, Chua W, Lin P, Horvath L, Bastick P, Butler P, Zhang AY, Yip S, Thomas H, Langford A, Hofman MS, McJannett M, Martin AJ, Stockler MR, Davis ID; ENZA-p Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Emmett L, et al. Among authors: butler p. Lancet Oncol. 2024 May;25(5):563-571. doi: 10.1016/S1470-2045(24)00135-9. Epub 2024 Apr 12. Lancet Oncol. 2024. PMID: 38621400 Clinical Trial.
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Savarirayan R, Hoover-Fong J, Irving M, Arundel P, de Bergua JM, Campeau PM, Candler T, Cocanougher BT, Cormier-Daire V, Edouard T, Fredwall SO, Harmatz P, Hoernschemeyer D, Irgens HU, Jamuar S, Kannu P, Legare JM, Leiva-Gea A, McDevitt H, Onesimo R, Phillips J 3rd, Del Pino M, Robinson ME, Rossi M, Skae M, Ward LM, White KK, Schmidt J, Lystig T, Salvatici A, Bai Y, Butler PW, van Veenhuyzen D, Rogoff D. Savarirayan R, et al. Among authors: butler pw. N Engl J Med. 2026 Sep 3;395(9):859-869. doi: 10.1056/NEJMoa2604565. Epub 2026 Jun 28. N Engl J Med. 2026. PMID: 42370681 Clinical Trial.
Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotype.
Miller ZA, Ossenkoppele R, Graff-Radford NR, Allen IE, Shwe W, Rosenberg L, Olguin DJ, Erkkinen MG, Butler PM, Spina S, Yokoyama JS, Desikan RS, Scheltens P, van der Flier W, Pijnenburg Y, Wolters E, Rademakers R, Geschwind DH, Kramer JH, Rosen HJ, Rankin KP, Grinberg LT, Seeley WW, Sturm V, Perry DC, Miller BL, Rabinovici GD, Gorno-Tempini ML. Miller ZA, et al. Among authors: butler pm. Alzheimers Dement. 2025 Sep;21(9):e70668. doi: 10.1002/alz.70668. Alzheimers Dement. 2025. PMID: 40959879 Free PMC article.
Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial.
Emmett L, Subramaniam S, Crumbaker M, Joshua AM, Sandhu S, Nguyen A, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Gedye C, Rutherford NK, Kumar ASR, Pook D, Ramdave S, Nadebaum DP, Voskoboynik M, Redfern AD, Macdonald W, Krieger L, Schembri G, Chua W, Lin P, Horvath L, Bastick P, Butler P, Zhang AY, McJannett M, Thomas H, Langford A, Hofman MS, Martin AJ, Davis ID, Stockler MR; ENZA-p Trial Investigators; Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Emmett L, et al. Among authors: butler p. Lancet Oncol. 2025 Mar;26(3):291-299. doi: 10.1016/S1470-2045(25)00009-9. Epub 2025 Feb 13. Lancet Oncol. 2025. PMID: 39956124 Clinical Trial.
Combination of Measurements of the Top Quark Mass from Data Collected by the ATLAS and CMS Experiments at sqrt[s]=7 and 8 TeV.
Hayrapetyan A, Tumasyan A, Adam W, Andrejkovic JW, Bergauer T, Chatterjee S, Damanakis K, Dragicevic M, Hussain PS, Jeitler M, Krammer N, Li A, Liko D, Mikulec I, Schieck J, Schöfbeck R, Schwarz D, Sonawane M, Templ S, Waltenberger W, Wulz CE, Darwish MR, Janssen T, Van Mechelen P, Bols ES, D'Hondt J, Dansana S, De Moor A, Delcourt M, El Faham H, Lowette S, Makarenko I, Müller D, Sahasransu AR, Tavernier S, Tytgat M, Van Putte S, Vannerom D, Clerbaux B, De Lentdecker G, Favart L, Hohov D, Jaramillo J, Khalilzadeh A, Lee K, Mahdavikhorrami M, Malara A, Paredes S, Pétré L, Postiau N, Thomas L, Vanden Bemden M, Vander Velde C, Vanlaer P, De Coen M, Dobur D, Hong Y, Knolle J, Lambrecht L, Mestdach G, Rendón C, Samalan A, Skovpen K, Van Den Bossche N, van der Linden J, Wezenbeek L, Benecke A, Bruno G, Caputo C, Delaere C, Donertas IS, Giammanco A, Jaffel K, Jain S, Lemaitre V, Lidrych J, Mastrapasqua P, Mondal K, Tran TT, Wertz S, Alves GA, Coelho E, Hensel C, Menezes De Oliveira T, Moraes A, Rebello Teles P, Soeiro M, Aldá Júnior WL, Alves Gallo Pereira M, Barroso Ferreira Filho M, Brandao Malbouisson H, Carvalho W, Chinellato J, Da Costa EM, Da Silveira GG, De Jesus Damiao D, Fonseca… See abstract for full author list ➔ Hayrapetyan A, et al. Among authors: butler ph. Phys Rev Lett. 2024 Jun 28;132(26):261902. doi: 10.1103/PhysRevLett.132.261902. Phys Rev Lett. 2024. PMID: 38996325 Free article.
When excellence is still not enough.
Butler PD. Butler PD. Am J Surg. 2020 Sep;220(3):543-544. doi: 10.1016/j.amjsurg.2020.06.015. Epub 2020 Jun 17. Am J Surg. 2020. PMID: 32622506 No abstract available.
Examination of Intersectionality and the Pipeline for Black Academic Surgeons.
Keshinro A, Butler P, Fayanju O, Khabele D, Newman E, Greene W, Ude Welcome A, Joseph KA, Stallion A, Backhus L, Frangos S, DiMaggio C, Berman R, Hasson R, Rodriguez LM, Stain S, Bukur M, Klein MJ, Henry-Tillman R, Barry L, Oseni T, Martin C, Johnson-Mann C, Smith R, Karpeh M, White C, Turner P, Pugh C, Hayes-Jordan A, Berry C. Keshinro A, et al. Among authors: butler p. JAMA Surg. 2022 Apr 1;157(4):327-334. doi: 10.1001/jamasurg.2021.7430. JAMA Surg. 2022. PMID: 35138327 Free PMC article.
Pear-shaped atomic nuclei.
Butler PA. Butler PA. Proc Math Phys Eng Sci. 2020 Jul;476(2239):20200202. doi: 10.1098/rspa.2020.0202. Epub 2020 Jul 1. Proc Math Phys Eng Sci. 2020. PMID: 32821242 Free PMC article.
1,993 results